281 related articles for article (PubMed ID: 21703303)
1. Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology.
Frisardi V; Panza F; Seripa D; Farooqui T; Farooqui AA
Prog Lipid Res; 2011 Oct; 50(4):313-30. PubMed ID: 21703303
[TBL] [Abstract][Full Text] [Related]
2. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
[TBL] [Abstract][Full Text] [Related]
3. A novel lysophosphatidic acid acyltransferase enzyme (LPAAT4) with a possible role for incorporating docosahexaenoic acid into brain glycerophospholipids.
Eto M; Shindou H; Shimizu T
Biochem Biophys Res Commun; 2014 Jan; 443(2):718-24. PubMed ID: 24333445
[TBL] [Abstract][Full Text] [Related]
4. Oxidized Docosahexaenoic Acid Species and Lipid Peroxidation Products Increase Amyloidogenic Amyloid Precursor Protein Processing.
Grimm MO; Haupenthal VJ; Mett J; Stahlmann CP; Blümel T; Mylonas NT; Endres K; Grimm HS; Hartmann T
Neurodegener Dis; 2016; 16(1-2):44-54. PubMed ID: 26642316
[TBL] [Abstract][Full Text] [Related]
5. The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease.
Belkouch M; Hachem M; Elgot A; Lo Van A; Picq M; Guichardant M; Lagarde M; Bernoud-Hubac N
J Nutr Biochem; 2016 Dec; 38():1-11. PubMed ID: 27825512
[TBL] [Abstract][Full Text] [Related]
6. Exploring the molecular approach of COX and LOX in Alzheimer's and Parkinson's disorder.
Kumar A; Behl T; Jamwal S; Kaur I; Sood A; Kumar P
Mol Biol Rep; 2020 Dec; 47(12):9895-9912. PubMed ID: 33263931
[TBL] [Abstract][Full Text] [Related]
7. Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: Can we reconcile the evidence?
Cunnane SC; Chouinard-Watkins R; Castellano CA; Barberger-Gateau P
Prostaglandins Leukot Essent Fatty Acids; 2013 Jan; 88(1):61-70. PubMed ID: 22575581
[TBL] [Abstract][Full Text] [Related]
8. Interactions between neural membrane glycerophospholipid and sphingolipid mediators: a recipe for neural cell survival or suicide.
Farooqui AA; Horrocks LA; Farooqui T
J Neurosci Res; 2007 Jul; 85(9):1834-50. PubMed ID: 17393491
[TBL] [Abstract][Full Text] [Related]
9. Lipid mediators and their metabolism in the nucleous: implications for Alzheimer's disease.
Farooqui AA
J Alzheimers Dis; 2012; 30 Suppl 2():S163-78. PubMed ID: 21955817
[TBL] [Abstract][Full Text] [Related]
10. Tracking the glycerophospholipid distribution of docosahexaenoic acid by shotgun lipidomics.
Mitchell TW
Methods Mol Biol; 2009; 579():19-31. PubMed ID: 19763469
[TBL] [Abstract][Full Text] [Related]
11. Effects of Dietary Supplementation with EPA-enriched Phosphatidylcholine and Phosphatidylethanolamine on Glycerophospholipid Profile in Cerebral Cortex of SAMP8 Mice fed with High-fat Diet.
Zhang C; Zhou MM; Zhang TT; Cong PX; Xu J; Xue CH; Yanagita T; Wei ZH; Wang YM
J Oleo Sci; 2021 Feb; 70(2):275-287. PubMed ID: 33456004
[TBL] [Abstract][Full Text] [Related]
12. Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders.
Farooqui AA; Horrocks LA; Farooqui T
Chem Phys Lipids; 2000 Jun; 106(1):1-29. PubMed ID: 10878232
[TBL] [Abstract][Full Text] [Related]
13. Characterization of brain-derived extracellular vesicle lipids in Alzheimer's disease.
Su H; Rustam YH; Masters CL; Makalic E; McLean CA; Hill AF; Barnham KJ; Reid GE; Vella LJ
J Extracell Vesicles; 2021 May; 10(7):e12089. PubMed ID: 34012516
[TBL] [Abstract][Full Text] [Related]
14. Modulation of inflammation in brain: a matter of fat.
Farooqui AA; Horrocks LA; Farooqui T
J Neurochem; 2007 May; 101(3):577-99. PubMed ID: 17257165
[TBL] [Abstract][Full Text] [Related]
15. Selectivity of phospholipid hydrolysis by phospholipase A
Astudillo AM; Balboa MA; Balsinde J
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Jun; 1864(6):772-783. PubMed ID: 30010011
[TBL] [Abstract][Full Text] [Related]
16. Dietary Fatty Acid Factors in Alzheimer's Disease: A Review.
Zhang T; Han X; Zhang X; Chen Z; Mi Y; Gou X
J Alzheimers Dis; 2020; 78(3):887-904. PubMed ID: 33074226
[TBL] [Abstract][Full Text] [Related]
17. [The present-day look at lipid peroxidation].
Luczaj W; Skrzydlewska E
Postepy Biochem; 2006; 52(2):173-9. PubMed ID: 17078507
[TBL] [Abstract][Full Text] [Related]
18. Dietary fatty acids in dementia and predementia syndromes: epidemiological evidence and possible underlying mechanisms.
Solfrizzi V; Frisardi V; Capurso C; D'Introno A; Colacicco AM; Vendemiale G; Capurso A; Panza F
Ageing Res Rev; 2010 Apr; 9(2):184-99. PubMed ID: 19643207
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic acid abundance in the brain: a biodevice to combat oxidative stress.
Yavin E; Brand A; Green P
Nutr Neurosci; 2002 Jun; 5(3):149-57. PubMed ID: 12041873
[TBL] [Abstract][Full Text] [Related]
20. Shortage of lipid-radical cycles in membranes as a possible prime cause of energetic failure in aging and Alzheimer disease.
Dmitriev LF
Neurochem Res; 2007 Aug; 32(8):1278-91. PubMed ID: 17541743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
